PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Xuanshen Yishen Decoction (XYD) plus antihypertensive regimen showed a higher attainment rate of intensive blood pressure control (17.5%) compared to antihypertensive regimen alone (8.09%) [PMID:40372581].
Aqueous extract of S. ningpoensis improves insulin sensitivity through AMPK-mediated inhibition of the NLRP3 inflammasome [PMID:35792447]; Angoroside C alleviates metabolic syndrome in db/db mice [PMID:40440908].
Xuanshen decoction (XSD) significantly alleviated symptoms of loperamide-induced slow transit constipation in rats [PMID:40904888].
S. ningpoensis can relieve nephrogenic edema by regulating renal function and reducing inflammation [PMID:37814466].
Polysaccharides from S. ningpoensis improved reserpine-induced depression-like behavior by restoring monoamine neurotransmitter homeostasis and hippocampal neurogenesis [PMID:39884598].
Evidence summary
PubMed sources
- 1.PMID: 33338592 (2021) — Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl. · Journal of ethnopharmacology
- 2.PMID: 28867715 (2017) — New Iridoids from Scrophularia ningpoensis. · Chemical & pharmaceutical bulletin
- 3.PMID: 39884598 (2025) — Polysaccharides from Scrophularia ningpoensis Hemsl. improve reserpine-induced depression-like behavior by inhibiting HTR2A/HTR2C mediated AKT/GSK3β/β-catenin/CBP/BDNF signalling. · International journal of biological macromolecules
- 4.PMID: 37814466 (2024) — A metabolism-based study of the mechanism of action of Scrophularia ningpoensis Hemsl. on nephrogenic edema. · Biomedical chromatography : BMC
- 5.PMID: 38601543 (2024)